Ajanta Pharma P/E Ratio
Ajanta Pharma P/E ratio. Ajanta Pharma (AJANTPHARM) P/E ratio is 32.5 (High), EPS (TTM) ₹84.53, current price ₹3270.30 on NSE vs historical average P/E of 21.47 (90.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Ajanta Pharma share price chart.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
AJANTPHARM P/E Ratio — Valuation Signal & Historical Context
Ajanta Pharma P/E 32.5 vs historical average 21.47, range 9.1–36.89 — signal: Overvalued. Also explore AJANTPHARM stock price history to track price trends across different timeframes.
- Stock appears overvalued with PE of 32.5, suggesting caution for new investments
- Current PE is 51.4% above historical average
- Trading at discount to sector average PE of 52.27
Ajanta Pharma P/E Ratio Historical Trend
AJANTPHARM annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 32.5 vs historical average 21.47. Check AJANTPHARM company valuation to track the company's total market size over time.
AJANTPHARM Historical P/E Ratio — EPS, Year-End Price & Valuation
Ajanta Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 36.89 | 81.18 | ₹2994.35 | NSE | High |
| 2024 | 30.2 | 71.51 | ₹2159.65 | NSE | High |
| 2023 | 20.73 | 58.26 | ₹1207.75 | NSE | Moderate |
| 2022 | 27.31 | 54.05 | ₹1476.15 | NSE | High |
| 2021 | 14.53 | 75.74 | ₹1100.70 | NSE | Low |
| 2020 | 9.1 | 71.65 | ₹652.30 | NSE | Low |
| 2019 | 16.11 | 48.91 | ₹787.80 | NSE | Moderate |
| 2018 | 22.32 | 44.61 | ₹995.85 | NSE | Moderate |
| 2017 | 21.92 | 55.48 | ₹1215.90 | NSE | Moderate |
| 2016 | 15.58 | 57.0 | ₹887.95 | NSE | Moderate |
AJANTPHARM vs Healthcare Peers — P/E Ratio Comparison
Ajanta Pharma P/E 32.5 vs Healthcare average 52.27, median 29.4 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |